Celltrion, Hospira plot Aussie rollout of Remicade biosim; Sun Pharma quarter suffers on U.S. slowdown, Ranbaxy;

@FiercePharma: Real-time data can put slow drug launches into the fast lane, researcher says. More from FiercePharmaMarketing | Follow @FiercePharma

@EricPFierce: GSK stops production at North Carolina plant after Legionella bacteria found in cooling tower. News | Follow @EricPFierce

@CarlyHFierce: Ironwood steps up to challenge Valeant with Allergan's IBS med Viberzi. FiercePharmaMarketing story | Follow @CarlyHFierce

> Biosimilars maker Celltrion won Australian approval to sell its knockoff version of the anti-inflammatory blockbuster Remicade; partner Hospira ($HSP), soon to be part of Pfizer ($PFE), will take on marketing duties there. Report

> A slowdown in U.S. sales and the integration of Ranbaxy Laboratories took their toll on Sun Pharma's quarterly results, with profits falling as expected. Report

> India's Zydus Cadila said its quarterly net profit increased by almost half, thanks to a sales leap in the U.S. of 37%. Release

> Allergan ($AGN) confirmed that it's challenging Merck & Co.'s ($MRK) patent protection on the antifungal Noxafil and said it may be the first-to-file generics company for that drug. Release

> Britain's competition watchdog ordered Reckitt Benckiser to license out its K-Y brand in the region for 8 years to combat worries about its purchasing the product line from Johnson & Johnson ($JNJ). Report

> Me-too drugs may be due for an image overhaul now that competitive rivalries are helping bring down prices in some areas. Report

> India-based Claris Lifesciences won FDA approval to resume supplying its furosemide injection to the U.S. Report

Medical Device News

@FierceMedDev: ICYMI yesterday: Rehabilitation startup rolls out new muscle therapy device for leg paralysis. Story | Follow @FierceMedDev

@VarunSaxena2: Study: Device industry suffers from first-mover disadvantage due to FDA regs. Article | Follow @VarunSaxena2

@EmilyWFierce: UPDATED: Kim Kardashian Instagram post lands Duchesnay in FDA hot water. More from FiercePharmaManufacturing | Follow @EmilyWFierce

> New York startup trots out video-game like screening device for Alzheimer's. Story

> Helius enters clinical trial of its PoNS brain stimulation device to treat traumatic brain injury. More

> Wearable pain relief device set to hit store shelves due to distribution alliance. Report

Biotech News

@FierceBiotech: We're looking for 2015's Fiercest women in biotech. More | Follow @FierceBiotech

@JohnCFierce: What does Google's corporate shuffle mean for its biotech ambitions? Story | Follow @JohnCFierce

@DamianFierce: A wonderfully stern FDA official parses Kim Kardashian's Instagram. Warning letter | Follow @DamianFierce

> Sickle cell biotech GBT banks $120M in an above-range IPO. Article

> Post-Sarepta, Art Krieg gets $20M to take a shot at an immuno-oncology Checkmate. Story

> Nearing the brink, Eleven Bio bets it all on another PhIII eye study. More

Biotech Research News

> Vitamin B3 pathway may lead to new obesity drugs. Item

> MGH study pinpoints a genetic trigger for heart valve disorder. Report

> UBC team stakes a claim on a newly discovered 'obesity gene.' More

> Overstimulating oncogene family SRC shows promise against cancer. Story

> TSRI researchers say enzyme may work as an anti-smoking treatment. Article

Diagnostics News

> VisionGate sets sights on FDA approval for noninvasive lung cancer Dx. Editor's corner

> Biocept partners with UC Irvine on liquid biopsy research. News

> Response Genetics throws in towel, sells out to Cancer Genetics for $14M. More

> Roche selects Hawaii's Diagnostic Laboratory Services for molecular diagnostics project. Report

> Invitae dials up testing guidance amid positive Q2 numbers. Article

Pharma Marketing News

> Legionnaires' discovery prompts GlaxoSmithKline to idle NC plant. Item

> Real-time data can put slow drug launches into the fast lane, researcher says. Report

> Abbott, Novartis tap into #ILookLikeAnEngineer social media movement. More

> Kim Kardashian Instagram post lands Duchesnay in FDA hot water. Story

> Ironwood steps up to challenge Valeant with Allergan's IBS med Viberzi. Article

And Finally ... A Winnipeg, Canada, pharmacy was charged with smuggling bad cancer drugs to U.S. customers. Report

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.